Effect of an acceptance, mindfulness and compassionate-based group intervention in overweight and obese women

Determining the efficacy of an acceptance, mindfulness and compassionate-based group intervention in overweight and obese women and its effect on metabolic syndrome components

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190924044866N1

Enrollment

Registered

2019-10-27

Start date

2019-10-22

Completion date

Unknown

Last updated

2019-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity and overweight. Overweight and obesity

Interventions

Intervention 1: Intervention group: Obese and overweight with a body mass index (25 = BMI)- Treatment protocol of acceptance, mindfulness and compassion (Kg-free) by Palmira and et al at the research

Eligibility

Sex/Gender

Female

Age

40 Years to 65 Years

Inclusion criteria

Inclusion criteria: BMI (25= BMI) Reading and writing literacy Age range 40-65 Lack of severe knee osteoarthritis (if possible with regular attendance at sessions)

Exclusion criteria

Exclusion criteria: Medical illnesses affecting weight, such as glandular disease, including thyroid problems, diabetes, Pregnant women, lactating Use of drugs that change weight and appetite d) Impossible to attend weekly sessions Severe psychiatric illness

Design outcomes

Primary

Measure	Time frame
Triglycerides levels of individuals in test. Timepoint: Per-intervention, mid intervention and post-intervention and follow up. Method of measurement: To evaluate and check-up of triglyceride participants will be introduced to the laboratory.;Blood glucose levels of individuals in test. Timepoint: Per-intervention, mid intervention and post-intervention and follow up. Method of measurement: To evaluate and check-up of blood glucose participants will be introduced to the laboratory.;High-density lipoprotein (HDL) levels of individuals in test. Timepoint: Per-intervention, mid intervention and post-intervention and follow up. Method of measurement: To evaluate and check-up of High-density lipoprotein (HDL) participants will be introduced to the laboratory.;Blood pressure levels of individuals in test. Timepoint: Per-intervention, mid intervention and post-intervention and follow up. Method of measurement: To evaluate and check-up of blood pressure participants will be introduced to the laboratory.;Thyroid levels of individuals in test. Timepoint: Per-intervention, mid intervention and post-intervention and follow up. Method of measurement: To evaluate and check-up of thyroid participants will be introduced to the laboratory.	—

Measure

Time frame

Triglycerides levels of individuals in test. Timepoint: Per-intervention, mid intervention and post-intervention and follow up. Method of measurement: To evaluate and check-up of triglyceride participants will be introduced to the laboratory.;Blood glucose levels of individuals in test. Timepoint: Per-intervention, mid intervention and post-intervention and follow up. Method of measurement: To evaluate and check-up of blood glucose participants will be introduced to the laboratory.;High-density lipoprotein (HDL) levels of individuals in test. Timepoint: Per-intervention, mid intervention and post-intervention and follow up. Method of measurement: To evaluate and check-up of High-density lipoprotein (HDL) participants will be introduced to the laboratory.;Blood pressure levels of individuals in test. Timepoint: Per-intervention, mid intervention and post-intervention and follow up. Method of measurement: To evaluate and check-up of blood pressure participants will be introduced to the laboratory.;Thyroid levels of individuals in test. Timepoint: Per-intervention, mid intervention and post-intervention and follow up. Method of measurement: To evaluate and check-up of thyroid participants will be introduced to the laboratory.

—

Secondary

Measure	Time frame
Eating. Timepoint: Per-intervention, mid intervention and post-intervention and follow up. Method of measurement: Three-Factor Eating Questionnaire.;Acceptance and Action for Weight-Related Difficulties. Timepoint: Per-intervention, mid intervention and post-intervention and follow up. Method of measurement: Acceptance and Action Questionnaire for Weight-Related Difficulties (AAQW).;Quality of Life. Timepoint: Per-intervention, mid intervention and post-intervention and follow up. Method of measurement: Who Quality of Life-BREF.;Sexual Function. Timepoint: Per-intervention, mid intervention and post-intervention and follow up. Method of measurement: Female Sexual Function Index-FSFI.	—

Measure

Time frame

Eating. Timepoint: Per-intervention, mid intervention and post-intervention and follow up. Method of measurement: Three-Factor Eating Questionnaire.;Acceptance and Action for Weight-Related Difficulties. Timepoint: Per-intervention, mid intervention and post-intervention and follow up. Method of measurement: Acceptance and Action Questionnaire for Weight-Related Difficulties (AAQW).;Quality of Life. Timepoint: Per-intervention, mid intervention and post-intervention and follow up. Method of measurement: Who Quality of Life-BREF.;Sexual Function. Timepoint: Per-intervention, mid intervention and post-intervention and follow up. Method of measurement: Female Sexual Function Index-FSFI.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli Asgharzade

Iran University of Medical Sciences

ali.asgharzadeh72@gmail.com+98 41 4212 5220

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026